FDA Inspection 785017 — SpecGx LLC
The FDA completed an inspection of SpecGx LLC on June 5, 2012 in Greenville, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 5, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Greenville, IL (United States)